GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Sunzen Biotech Bhd (XKLS:0148) » Definitions » Cyclically Adjusted PS Ratio

Sunzen Biotech Bhd (XKLS:0148) Cyclically Adjusted PS Ratio : 1.23 (As of Jun. 05, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sunzen Biotech Bhd Cyclically Adjusted PS Ratio?

As of today (2024-06-05), Sunzen Biotech Bhd's current share price is RM0.38. Sunzen Biotech Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was RM0.31. Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio for today is 1.23.

The historical rank and industry rank for Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKLS:0148' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.56   Med: 0.77   Max: 1.29
Current: 1.23

During the past years, Sunzen Biotech Bhd's highest Cyclically Adjusted PS Ratio was 1.29. The lowest was 0.56. And the median was 0.77.

XKLS:0148's Cyclically Adjusted PS Ratio is ranked worse than
63.24% of 1382 companies
in the Consumer Packaged Goods industry
Industry Median: 0.79 vs XKLS:0148: 1.23

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sunzen Biotech Bhd's adjusted revenue per share data for the three months ended in Mar. 2024 was RM0.030. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is RM0.31 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Sunzen Biotech Bhd Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunzen Biotech Bhd Cyclically Adjusted PS Ratio Chart

Sunzen Biotech Bhd Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.68 0.88

Sunzen Biotech Bhd Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.67 0.69 0.69 0.67 1.07

Competitive Comparison of Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio

For the Packaged Foods subindustry, Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio falls into.



Sunzen Biotech Bhd Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.38/0.31
=1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunzen Biotech Bhd's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Sunzen Biotech Bhd's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.03/131.7762*131.7762
=0.030

Current CPI (Mar. 2024) = 131.7762.

Sunzen Biotech Bhd Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.033 99.695 0.044
201406 0.035 100.560 0.046
201409 0.030 100.428 0.039
201412 0.037 99.070 0.049
201503 0.028 99.621 0.037
201506 0.031 100.684 0.041
201509 0.018 100.392 0.024
201512 0.022 99.792 0.029
201603 0.023 100.470 0.030
201606 0.026 101.688 0.034
201609 0.019 101.861 0.025
201612 0.024 101.863 0.031
201703 0.090 102.862 0.115
201706 0.144 103.349 0.184
201709 0.144 104.136 0.182
201712 0.192 104.011 0.243
201803 0.147 105.290 0.184
201806 0.104 106.317 0.129
201809 0.202 106.507 0.250
201812 0.137 105.998 0.170
201903 0.127 107.251 0.156
201906 0.133 108.070 0.162
201909 0.118 108.329 0.144
201912 0.085 108.420 0.103
202003 0.040 108.902 0.048
202006 0.024 108.767 0.029
202009 0.038 109.815 0.046
202012 0.053 109.897 0.064
202103 0.045 111.754 0.053
202106 0.038 114.631 0.044
202109 0.027 115.734 0.031
202112 0.047 117.630 0.053
202203 0.044 121.301 0.048
202206 0.040 125.017 0.042
202209 0.033 125.227 0.035
202212 0.017 125.222 0.018
202303 0.031 127.348 0.032
202306 0.027 128.729 0.028
202309 0.036 129.860 0.037
202403 0.030 131.776 0.030

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Sunzen Biotech Bhd  (XKLS:0148) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Sunzen Biotech Bhd Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Sunzen Biotech Bhd's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Sunzen Biotech Bhd (XKLS:0148) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, Jalan Anggerik Mokara 31/47, Kota Kemuning, Shah Alam, SGR, MYS, 40460
Sunzen Biotech Bhd is engaged in the business of research and development of biotechnology and manufacturing and marketing of animal health products. The company operates in the business segments of Manufacturing and trading animal health products; Trading and processing of crude palm oil and related products; Traditional Chinese medicines and herbal health foods and beverages and loan financing. It generates key revenue from the Traditional Chinese medicines and herbal health foods and beverages segment.

Sunzen Biotech Bhd (XKLS:0148) Headlines

No Headlines